You are here: Industry Insights > ANI Pharmaceuticals

News List

Edge Pharma Completes Supplier Agreement with ANI contractpharma
June 28, 2020
Will market the company's FDA approved Vancomycin Hydrochloride for Oral Solution.
ANI Files Prior Approval Supplement for Purified Cortrophin Gel 80 U/mL americanpharmaceuticalreview
March 27, 2020
ANI Pharmaceuticals has submitted a prior approval supplement (PAS) to the Endocrinology Division at the FDA for re-commercialization of Purified Cortrophin® Gel (Repository Corticotropin Injection USP) (80 U/mL).
ANI Pharmaceuticals Announces Approval of Morphine Sulfate Oral Solution biospace
April 19, 2018
ANI Pharmaceuticals, Inc.today announced that it has received approval from FDA of its Abbreviated New Drug Application ("ANDA") for Morphine Sulfate Oral Solution 10mg/5mL, 20mg/5mL and 100mg/5mL.
AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal biospace
January 02, 2018
ANI Pharmaceuticals, Inc. today announced that it has received $ 45 million in cash from the NDA and AstraZeneca Inc.'s ATACAND®, ATACANDHCT®, ARIMIDEX®, and CASODEX® in the United States
ANI Pharmaceuticals Acquires Inderal® XL and InnoPran XL® americanpharmaceuticalreview
February 27, 2017
ANI Pharmaceuticals has acquired Inderal® XL from Cranford Pharmaceuticals, LLC and InnoPran XL® from Holmdel Pharmaceuticals LP.